Literature DB >> 1489248

Cholinergic microstimulation of the peribrachial nucleus in the cat. I. Immediate and prolonged increases in ponto-geniculo-occipital waves.

S Datta1, J M Calvo, J Quattrochi, J A Hobson.   

Abstract

The cholinergic agonist carbachol was injected into the pontine Pb area where PGO bursting cells have been recorded. When microinjections were localized to the ventrolateral aspect of the caudal Pb nucleus near aggregates of ChAT immunolabeled cholinergic neurons, carbachol produced an immediate onset of state-independent PGO waves in the ipsilateral LGB. These state-independent PGO waves persisted for 3-4 days. After the first 24 hrs PGO wave activity increasingly became associated with REM sleep and with REM transitional SP sleep as both of these PGO-related states increased in amount to 3-4 times baseline levels. The increase in amount of PGO-related states peaked on days 2-4 following one carbachol injection and persisted for 10-12 days. These results suggest a two stage process: stage one, PGO enhancement, is the direct consequence of the membrane activation of cholinoceptive PGO burst neurons by carbachol; stage two, REM enhancement, is the consequence of metabolic activation of endogenous cholinergic neurons. This experimental preparation is a useful model for the study of the electrophysiology and functional significance of PGO wave and REM sleep generation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489248

Source DB:  PubMed          Journal:  Arch Ital Biol        ISSN: 0003-9829            Impact factor:   1.000


  12 in total

1.  Injection of glutamate into the pedunculopontine tegmental nuclei of anesthetized rat causes respiratory dysrhythmia and alters EEG and EMG power.

Authors:  Jasna Saponjic; Miodrag Radulovacki; David W Carley
Journal:  Sleep Breath       Date:  2005-06       Impact factor: 2.816

Review 2.  Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.

Authors:  Subimal Datta; Robert Ross Maclean
Journal:  Neurosci Biobehav Rev       Date:  2007-03-12       Impact factor: 8.989

Review 3.  Cellular basis of pontine ponto-geniculo-occipital wave generation and modulation.

Authors:  S Datta
Journal:  Cell Mol Neurobiol       Date:  1997-06       Impact factor: 5.046

4.  Coupling of hippocampal theta and ripples with pontogeniculooccipital waves.

Authors:  Juan F Ramirez-Villegas; Michel Besserve; Yusuke Murayama; Henry C Evrard; Axel Oeltermann; Nikos K Logothetis
Journal:  Nature       Date:  2020-11-18       Impact factor: 49.962

5.  A restricted parabrachial pontine region is active during non-rapid eye movement sleep.

Authors:  P Torterolo; S Sampogna; M H Chase
Journal:  Neuroscience       Date:  2011-06-15       Impact factor: 3.590

6.  Modulation of respiratory pattern and upper airway muscle activity by the pedunculopontine tegmentum: role of NMDA receptors.

Authors:  Jasna Saponjic; Miodrag Radulovacki; David W Carley
Journal:  Sleep Breath       Date:  2006-12       Impact factor: 2.816

7.  Avoidance task training potentiates phasic pontine-wave density in the rat: A mechanism for sleep-dependent plasticity.

Authors:  S Datta
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

8.  Activation of phasic pontine-wave generator in the rat: a mechanism for expression of plasticity-related genes and proteins in the dorsal hippocampus and amygdala.

Authors:  Subimal Datta; Guangmu Li; Sanford Auerbach
Journal:  Eur J Neurosci       Date:  2008-03-26       Impact factor: 3.386

Review 9.  Waking and dreaming consciousness: neurobiological and functional considerations.

Authors:  J A Hobson; K J Friston
Journal:  Prog Neurobiol       Date:  2012-05-15       Impact factor: 11.685

10.  State-dependent brainstem ensemble dynamics and their interactions with hippocampus across sleep states.

Authors:  Tomomi Tsunematsu; Amisha A Patel; Arno Onken; Shuzo Sakata
Journal:  Elife       Date:  2020-01-14       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.